These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 15289888)
21. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells. Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527 [TBL] [Abstract][Full Text] [Related]
22. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice. Knight B; Tirnitz-Parker JE; Olynyk JK Gastroenterology; 2008 Sep; 135(3):969-79, 979.e1. PubMed ID: 18602920 [TBL] [Abstract][Full Text] [Related]
23. [Imatinib induces c-kit positive myeloma cells apoptosis]. Li J; Huang BH; Zhao Y; Luo SK Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):230-3. PubMed ID: 18843975 [TBL] [Abstract][Full Text] [Related]
24. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. Krystal GW; Honsawek S; Litz J; Buchdunger E Clin Cancer Res; 2000 Aug; 6(8):3319-26. PubMed ID: 10955819 [TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications. Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
27. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate). Mukherjee J; Kamnasaran D; Balasubramaniam A; Radovanovic I; Zadeh G; Kiehl TR; Guha A Cancer Res; 2009 Jun; 69(12):5099-107. PubMed ID: 19509233 [TBL] [Abstract][Full Text] [Related]
28. STI571 sensitizes nasopharyngeal carcinoma cells to cisplatin: sustained activation of ERK with improved growth inhibition. Sheu LF; Young ZH; Lee WC; Chen YF; Kao WY; Chen A Int J Oncol; 2007 Feb; 30(2):403-11. PubMed ID: 17203222 [TBL] [Abstract][Full Text] [Related]
29. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610 [TBL] [Abstract][Full Text] [Related]
30. STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. Pietras K; Stumm M; Hubert M; Buchdunger E; Rubin K; Heldin CH; McSheehy P; Wartmann M; Ostman A Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3779-87. PubMed ID: 14506171 [TBL] [Abstract][Full Text] [Related]
31. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898 [TBL] [Abstract][Full Text] [Related]
32. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells. Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435 [TBL] [Abstract][Full Text] [Related]
33. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
34. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo. Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987 [TBL] [Abstract][Full Text] [Related]
35. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Batra S; Reynolds CP; Maurer BJ Cancer Res; 2004 Aug; 64(15):5415-24. PubMed ID: 15289350 [TBL] [Abstract][Full Text] [Related]
36. The mechanism of STI571 inducing apoptosis of K562 cells. Qin Y; Chen S; Chang Y; Fu J; Wang X Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):289-92. PubMed ID: 12411057 [TBL] [Abstract][Full Text] [Related]
37. Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969 [TBL] [Abstract][Full Text] [Related]
38. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215 [TBL] [Abstract][Full Text] [Related]
39. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936 [TBL] [Abstract][Full Text] [Related]
40. Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration. Popow-Woźniak A; Woźniakowska A; Kaczmarek L; Malicka-Błaszkiewicz M; Nowak D Eur J Pharmacol; 2011 Sep; 667(1-3):66-73. PubMed ID: 21658383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]